预计结直肠癌市场规模将从 2022 年的 186.193 亿美元增长至 2028 年的 240.785 亿美元;预计2022 年至 2028 年的复合年增长率为 3.3%。
结直肠癌发病率的上升、产品上市以及仿制药带来的益处等因素正在推动全球结直肠癌市场的增长。然而,药品制造商面临的定价压力阻碍了市场的增长。
结直肠癌是大肠内壁的恶性肿瘤。这是由于异常细胞生长而导致的,这种异常细胞生长会侵袭或扩散到身体的其他部位。结直肠癌通常由炎症性肠病和遗传引起。疲劳、腹泻或便秘、呼吸短促、虚弱、排便习惯改变、大便带红色或深色血液、体重减轻、腹痛和腹胀是一些常见症状。结直肠癌分为四个阶段:0 期、I 期(结肠内层癌症)、II 期(癌症扩散到结肠肌肉壁)、III 期(癌症扩散到淋巴结)和 IV 期(癌症扩散到其他器官)。结直肠癌可以通过化疗、放疗和手术治疗。
定制此报告以满足您的需求
您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣
- 获取此报告的关键市场趋势。这个免费样品将包括数据分析,从市场趋势到估计和预测。
由于结直肠癌发病率不断上升、医疗基础设施改善、政府政策支持、跨国公司数量庞大以及人们对医疗保健诊断测试和设备的高度认识,北美很可能在预测期内主导结直肠癌市场。此外,美国在 2022 年占据了北美市场的最大份额,预计该国将在预测期内主导该地区市场。根据美国癌症协会的数据,结直肠癌是美国男性和女性中诊断出的第三大常见癌症,2021 年美国报告了约 104,270 例结肠癌新病例和 45,230 例直肠癌新病例。男性一生中被诊断出患有结直肠癌的风险约为 1/22,约占 5%。同样,对于女性来说,这一风险约为 1/24,约占 4.5%。癌症病例数量的增加增加了全国对结直肠癌治疗和诊断的需求。
全球结直肠癌市场按治疗方式、最终用户和地域进行细分。按地域划分,市场分为北美、欧洲、亚太地区、中东和非洲以及南美和中美洲。全球结直肠癌市场报告提供了对市场的深入分析和见解,重点关注市场趋势、技术进步、市场动态和全球领先市场参与者的竞争分析等参数。
市场洞察 结直肠癌发病
率上升
结直肠癌是个体中最常见且最致命的癌症之一,受遗传和环境因素共同影响。根据世界卫生组织 (WHO) 的数据,结直肠癌是第三大最常见的癌症,2020 年全球病例约为 193 万例,预计到 2030 年全球结直肠癌病例将增加约 70%。此外,根据美国国立卫生研究院的数据,结直肠癌 ( CRC ) 占所有癌症发病率的 9% 以上,是 2020 年全球发病和死亡的主要原因。此外,全球结直肠癌的死亡率和发病率各不相同,2020 年约有 916,000 人死于结直肠癌。它是男性第三大常见癌症和女性第二大常见癌症。男性一生中患结直肠癌的风险约为 1/23,女性约为 1/25。因此,结直肠癌被确定为第三大常见癌症和第二大致死癌症。
结直肠癌在亚洲国家人口中的影响越来越大。例如,根据国际癌症研究机构和 GLOBOCAN 的数据,亚洲结直肠癌的估计发病率在 2020 年报告了约 1,009,400 例新病例。与亚太地区的其他国家相比,日本、中国、马来西亚、新加坡、韩国和土耳其的发病率较高。
局部期结直肠癌患者五年后存活率为 90%。如果癌症扩散到邻近组织、器官或区域淋巴结,五年存活率为 71%。手术、免疫疗法、化疗、放射疗法和靶向疗法是结直肠癌最常见的治疗方法。根据癌症分期,可以同时或连续使用两种或两种以上的治疗方法。
因此,患有该疾病的患者数量的增加增加了对结直肠癌解决方案的需求,从而推动了全球结直肠癌市场的增长。
模式洞察
根据方式,全球结直肠癌市场分为诊断类型、治疗类型和成像类型。2022 年,诊断类型部分占据最大的市场份额,预计在预测期内将录得最高的复合年增长率。此外,诊断类型部分进一步分为免疫组织化学、粪便检查、柔性乙状结肠镜检查、结肠镜检查、CEA 测试等。由于患者进行的诊断测试数量不断增加,预计粪便测试部分将在预测期内录得市场最高复合年增长率。
结直肠癌市场区域洞察
Insight Partners 的分析师已详细解释了预测期内影响结直肠癌市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的结直肠癌市场细分和地理位置。
- 获取结直肠癌市场的区域特定数据
结直肠癌市场报告范围
报告属性 | 细节 |
---|---|
2022 年市场规模 | 186.2亿美元 |
2028 年市场规模 | 240.8亿美元 |
全球复合年增长率(2022 - 2028) | 3.3% |
史料 | 2020-2021 |
预测期 | 2023-2028 |
涵盖的领域 | 按方式
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
市场参与者密度:了解其对商业动态的影响
结直肠癌市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。
市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。
在结直肠癌市场运营的主要公司有:
- 安进公司
- 布鲁克公司
- 表观基因组学公司
- 临床基因组学技术有限公司
- VolitionRx有限公司
免责声明:上面列出的公司没有按照任何特定顺序排列。
- 了解结直肠癌市场顶级关键参与者概况
最终用户洞察
根据最终用户,全球结直肠癌市场分为医院和诊断与研究实验室。2022 年,医院部门将占据更大的市场份额,预计在预测期内将在市场上实现更高的复合年增长率。医院是拥有所有设施的最大实体。医院为患有各种疾病和病症的患者提供广泛的医疗保健和医疗服务。如今,医院为患者提供更好的服务。大量患者入院接受手术,而一些患者则前来接受诊断。在入院患者中,大多数患者已经患有一些疾病。因此,医院为全球结直肠癌市场贡献了相当大的市场份额,预计在预测期内将继续保持这一趋势。
许多急救和治疗中心需要对人体的器官、组织和功能进行检查,这些检查可以借助磁共振成像、CT 和 X 射线准确完成。由于需要持续的患者护理和监测,大多数手术都在医院进行。由于医院是人民的主要医疗保健中心,因此它很可能在预测的几年内推动最终用户细分市场的增长。因此,由于上述所有因素,未来几年医院细分市场的全球结直肠癌市场可能会增长。
产品发布和合作是全球结直肠癌市场参与者广泛采用的策略,以扩大其全球足迹和产品组合。参与者还专注于合作战略以扩大客户群,从而使他们能够在全球范围内保持品牌知名度。他们的目标是通过开发创新产品来扩大市场份额。以下列出了一些最近的关键市场发展:
- 2022 年 5 月,布鲁克为其市场领先的临床前磁共振成像 (MRI) 系统产品组合推出了创新的 7 特斯拉和 9.4 特斯拉传导冷却麦克斯韦磁体。继 BioSpec Maxwell 3 特斯拉型号取得成功之后,新推出的 Maxwell 7 特斯拉和 9.4 特斯拉磁体系列无需补充液氦或氮气,同时为先进的临床前 MRI 和 PET/MR 研究提供高场灵敏度和分辨率。
- 2022 年 1 月,安进与 Generate Biomedicines 达成研究合作协议,旨在发现和开发针对多个治疗领域和治疗模式的五个临床目标的蛋白质疗法。此次合作将加大药物研发力度,生成具有最佳治疗特性的新型蛋白质序列。
F. Hoffmann-La Roche AG、Epigenomics AG、Novigenix SA、Abbott Laboratories、Amgen Inc.、Volitionrx、EDP Biotech、Clinical Genomics Technologies Pvt Ltd、Bruker 和 Quest Diagnostics Incorporated 正在向市场提供产品和服务。
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Asia Pacific is expected to be the fastest growing region in colorectal cancer market over the forecast period due to developing healthcare infrastructure, enormous population base, growing prevalence of colorectal cancer patients, increased knowledge of the disease, growing government efforts, and technological improvement in the sector.
North America accounts for the major market share of colorectal cancer market in 2022 due to the increasing prevalence of colorectal cancer cases in the region and increased awareness about the disease.
The colorectal cancer market is expected to be valued at US$ 24,078.5 million in 2028.
The colorectal cancer market is analyzed in the basis of modality and end user. Based on modality, the market is segmented into diagnosis type, therapy type, and imaging type. The diagnosis type segment held the largest share of the market. Moreover, the same segment is anticipated to register the highest CAGR in the forecast period.
The colorectal cancer market is estimated to be valued at US$ 18,619.3 million in 2022.
The market is estimated to grow at a CAGR of 3.3% during the forecast period.
The colorectal cancer market majorly consists of the players, such as Epigenomics AG, Novigenix SA, Clinical Genomics Technologies Pty Ltd., EDP Biotech Corporation, Volitionrx Limited, Abbott Laboratories, Amgen Inc., F. Hoffmann-La Roche AG, Bruker Corporation, Quest Diagnostics Incorporated among others.
The factors that are driving the growth of market are rising prevalence of colorectal cancer, new product launches, and benefits offered by generic drugs boost the market growth. However, pricing pressure on drug manufacturers is the major factor hindering the colorectal cancer market growth.
Colorectal cancer is also known as bowel cancer, colon cancer, or rectal cancer. This type of cancer is the second leading cause of death in women and third in men. Colorectal cancer may be benign, or non-cancerous, or malignant. The symptoms shown by the patients who have colon cancer include changes in bowel habits, diarrhea or constipation, blood in stools that make it look black. Colorectal cancer can be treated with chemotherapy, radiotherapy, and surgery.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Colorectal Cancer Market
- Amgen Inc.
- Bruker Corporation
- Epigenomics AG
- Clinical Genomics Technologies Pty Ltd.
- VolitionRx Limited
- Novigenix SA
- F. Hoffmann-La Roche AG
- Abbott
- EDP Biotech
- Quest Diagnostics
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.